Leuko (Series A)
Funding Details
Awarder
Inbox
Date Award
September 23, 2022
Vertical
Healthcare Technology
Funding URL
View Funding Page
Funding Amount
$5,000,000
Company Info
Traction
Aims to reduce chemotherapy-related hospital readmissions by 50% and save over $6 billion annually in healthcare costs.
Founders
Carlos Castro-Gonzalez, Ian Butterworth, Aurelien Bourquard, Alvaro Sanchez-Ferro
Market
Cancer chemotherapy patients
Location
Boston, MA, USA
Coinvestors
Good Growth Capital, HTHIAG Capital Partners, Nina Capital
Company Description

Leuko is a startup spun out from MIT and the Madrid M+Vision Consortium, developing a platform technology, PointCheckTM, that combines optics and AI to make noninvasive blood testing easier, faster, and more accessible than state-of-the-art solutions.

Links
Website
Back to HomeBack to Healthcare Technology DealsView Funding Announcement